Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%

Trials by Status

recruiting250%
unknown125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruiting

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

NCT07773818
recruiting

Neurodevelopmental Disorders in Youth With Criminal Behaviors

NCT05875363
completed

hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics

NCT04744519
unknown

Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality

NCT04736160

Clinical Trials (4)

Showing 4 of 4 trials
NCT07773818

Establishment of a Multi-omics Prediction Model for Early Triple-negative Breast Cancer Based on UPGRADE-TNBC Study

Recruiting
NCT05875363

Neurodevelopmental Disorders in Youth With Criminal Behaviors

Recruiting
NCT04744519

hCG Concentration in Peripheral Maternal Blood After Embryo Transfer, Ongoing Pregnancy Rates, and Morphokinetics

Completed
NCT04736160

Pilot Study: hCG Secreted by Blastocyst as Potential Marker of Embryo Quality

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4